Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

26.67
Delayed Data
As of May 23
 0.00 / 0.00%
Today’s Change
19.67
Today|||52-Week Range
26.76
+23.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-121.0M-119.0M-239.0M347.0M
 
 
 
 
 
Depreciation689.0M725.0M769.0M815.0M
 
 
 
 
 
Total Other Cash Flow582.0M98.0M322.0M119.0M
 
 
 
 
 
Funds From Operations927.0M307.0M320.0M976.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-155.0M-962.0M-280.0M4.0M
 
 
 
 
 
Net Cash Flow - Operating Activities1.1B1.3B600.0M972.0M
 
 
 
 
 
 
InvestingIncrease In Investments-44.0M-26.0M-266.0M-132.0M
 
 
 
 
 
Decrease In Investments5.0M14.0M61.0M0.00
 
 
 
 
Capital Expenditures-245.0M-259.0M-247.0M-376.0M
 
 
 
 
 
Fixed Asset Disposal83.0M12.0M0.0029.0M
 
 
 
 
Net Assets From Acquisitions -274.0M-486.0M-1.7B-408.0M
 
 
 
 
 
Net Cash Flow Investing-475.0M-745.0M-2.2B-887.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings1.8B810.0M3.1B630.0M
 
 
 
 
 
Long Term Debt Reduction-1.8B-810.0M-1.7B-820.0M
 
 
 
 
 
Net Proceeds Stock Sale74.0M60.0M114.0M111.0M
 
 
 
 
 
Common Preferred Redeemed-500.0M-125.0M0.000.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----------
Other Uses - Financing160.0M85.0M222.0M127.0M
 
 
 
 
 
Net Cash Flow - Financing-596.0M-150.0M1.3B-206.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0M-4.0M-4.0M-2.0M
 
 
 
 
 
 
Net Change In Cash11.0M374.0M-264.0M-121.0M